Disclosures for "GHF-201, A Novel Oral Compound for Adult Polyglucosan Body Disease, Demonstrates Promising Safety and Efficacy in a Compassionate Use Program"
-
Or Kakhlon, PhD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Golden Heart Flower. Or Kakhlon, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Golden Heart Flower.
-
Mrs. MORDECHAI has nothing to disclose.
-
Prof. Garti has nothing to disclose.
-
Dr. Gilgun-Sherki has nothing to disclose.
-
Prof. Weil has nothing to disclose.
-
Dr. Lossos has nothing to disclose.